AnalystsSilvan TurkcanSilvan Turkcan's Stock Forecasts
AnalystsSilvan Turkcan
Sectors:
Industries:
Analyst Ranking
Bottom 8%
#5144 out of 5549 analysts
Average Return
-5.62%
Win Rate
29%8 out of 28
Risk vs Reward
Poor
Good
Silvan Turkcan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Relay Therapeutics IncRLAY | +89.77% | $10.26 | $19.47 | 2026-03-17 - 2026-10-29 | Buy |
Relay Therapeutics IncRLAY | +49.54% | $13.02 | $19.47 | 2026-05-20 - 2026-10-29 | Buy |
Relay Therapeutics IncRLAY | +49.42% | $13.03 | $19.47 | 2026-04-28 - 2026-10-29 | Buy |
Exelixis IncEXEL | +25.21% | $52.87 | $66.20 | 2026-06-24 - 2026-10-29 | Buy |
Crispr Therapeutics AgCRSP | +8.61% | $49.96 | $54.26 | 2026-01-30 - 2026-10-29 | Buy |
Silvan Turkcan Analyst Color
Get additional color on Silvan Turkcan's coverage of popular stocks
Silvan Turkcan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Exelixis IncEXEL | 2 | Buy | $65.00 | -1.81% | Maintains | 12 days ago |
Ascentage Pharma Group InternationalAAPG | 1 | Buy | $35.00 | +135.22% | Initiates Coverage On | 18 days ago |
Nuvation Bio IncNUVB | 1 | Buy | $10.00 | +109.64% | Reiterates | a month ago |
Cellectis SaCLLS | 2 | Hold | N/A | N/A | Downgrades | a month ago |
Intellia Therapeutics IncNTLA | 5 | Buy | $30.00 | +126.76% | Reiterates | 2 months ago |
Engene Therapeutics IncENGN | 2 | Hold | N/A | N/A | Reiterates | 2 months ago |
Ideaya Biosciences IncIDYA | 1 | Buy | $42.00 | +27.70% | Reiterates | 2 months ago |
Crispr Therapeutics AgCRSP | 4 | Buy | $80.00 | +47.44% | Reiterates | 2 months ago |
Tuhura Biosciences IncHURA | 2 | Buy | $9.00 | +336.89% | Reiterates | 2 months ago |
Celcuity IncCELC | 4 | Buy | $177.00 | +155.41% | Reiterates | 2 months ago |
Relay Therapeutics IncRLAY | 4 | Buy | $26.00 | +33.54% | Maintains | 3 months ago |
Bandwidth IncBAND | 1 | Buy | $86.00 | +61.93% | Maintains | 3 months ago |
Faeth Therapeutics IncFTH | 1 | Buy | $51.00 | +172.00% | Initiates Coverage On | 3 months ago |
Taysha Gene Therapies IncTSHA | 1 | Buy | $11.00 | +160.66% | Reiterates | 4 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.